Overview Vaginal Infection Study 2 Status: Completed Trial end date: 2009-11-01 Target enrollment: Participant gender: Summary This study will evaluate the efficacy and safety of a vaginal product compared with that of another vaginal product in the treatment of vaginal infections. Phase: Phase 3 Details Lead Sponsor: Lumara Health, Inc.Treatments: ButoconazoleClindamycinClindamycin palmitateClindamycin phosphate